Protein Supplementation and Muscle Recovery in Football (PRO-FOOTBALL)
Primary Purpose
Skeletal Muscle Damage, Muscle Inflammation, Muscle Recovery
Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Milk protein isolate
Placebo
Sponsored by
About this trial
This is an interventional basic science trial for Skeletal Muscle Damage
Eligibility Criteria
Inclusion Criteria:
- i) participation at elite level (top three division leagues) of soccer competition for at least five years, ii) abstain from consumption of performance-enhancing supplements, antioxidant supplements and medications (for at least 6 months before and during the study), iv) participate in at least six two-hour training sessions per week and played at least one match per week and v) non-smokers.
Exclusion Criteria:
- i) a known milk intolerance or allergy, ii) a recent febrile illness, iii) history of muscle lesion, iv) lower limb trauma and v) metabolic diseases.
Sites / Locations
- Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Protein
Placebo
Arm Description
On the match day, 25g of protein consumed immediately after the match and then 30g at 3h (+3h) and 25g at 6h (+6h). On each day of the remaining days, 20 g of protein consumed with breakfast.
On the match day, 500 ml received received orally immediately post-match and then at +3h and +6h. On the remaining days, 500 ml daily with breakfast.
Outcomes
Primary Outcome Measures
Change in creatine kinase in plasma
Concentration of creatine kinase will be measured in plasma
Change in uric acid in plasma
Concentration of uric acid will be measured in plasma
Change in protein carbonyls in blood
Concentration of protein carbonyls will be measured in red blood cells
Change in total antioxidant capacity
Total antioxidant capacity will be measured in plasma
Change in reduced glutathione in blood
Concentration of reduced glutathione will be measured in in red blood cells
Change in oxidized glutathione in blood
Concentration of oxidized glutathione will be measured in red blood cells
Change in malondialdehyde in blood
Concentration of malondialdehyde will be measured in serum
Change in catalase activity
Catalase activity will be measured in red blood cells
Change in protein carbonyls in muscle
Concentration of protein carbonyls will be measured in muscle
Change in intracellular signaling proteins in muscle
Phosphorylation levels of Akt, mammalian target of rapamycin (mTOR) and p70S6K will be measure using western blotting.
Change in proteasome activities in muscle
Chymotrypsin-like (CT-L), caspase-like (C-L) and trypsin-like (T-L) proteasome activities will be assayed with hydrolysis of the fluorogenic peptide LLVY-AMC, LLE-AMC and LSTR-AMC, respectively.
Change in satellite cells in muscle
Pax7, Myf5, MyoD and Myogenin will be measured in order to quantify quiescent, activated, proliferated-differentiated and fused satellite cells respectively.
Change in repeated Sprint Ability
5 x 30 m sprints will be performed with 25 seconds rest in-between. Mean time for 5 sprints and fatigue index will be calculated.
Change in countermovement jump
Countermovement jump will be assessed on a contact platform
Change in isokinetic strength of lower limbs
Isokinetic strength will be assessed on an isokinetic dynamometer for both knee extensors and knee flexors at 120 and 180 degrees.
Change in match activity
Match activity will be continuously recorded during both matches using GPS technology.
Change in heart rate
Heart rate will be continuously recorded during both matches using the Team Polar system.
Secondary Outcome Measures
Change in delayed onset of muscle soreness
Muscle soreness will assessed during palpation of the muscle belly and the distal region of relaxed vastus medialis, vastus lateralis and rectus femoris following three repetitions of of a full squat. Subjects will rate their DOMS on a visual analogue scale (0-10).
Dietary intake
Dietary intake will be assessed using 7-day diet recalls.
Change in white blood cell count.
White blood cell count will be measured using an automatic blood analyzer.
Full Information
NCT ID
NCT03348267
First Posted
November 15, 2017
Last Updated
January 26, 2018
Sponsor
University of Thessaly
1. Study Identification
Unique Protocol Identification Number
NCT03348267
Brief Title
Protein Supplementation and Muscle Recovery in Football
Acronym
PRO-FOOTBALL
Official Title
Effect of Milk Protein Supplementation on Muscle Recovery and Football-specific Performance During an In-season Microcycle With Two Matches
Study Type
Interventional
2. Study Status
Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
May 1, 2016 (Actual)
Primary Completion Date
June 30, 2016 (Actual)
Study Completion Date
September 15, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Thessaly
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Soccer is an intermittent sport including a high number of powerful actions such as accelerations, decelerations, changes of direction, jumps and impacts that incorporate a strong eccentric component and may therefore lead to skeletal muscle damage. Indeed, match activity is associated with the onset of muscle damage and an acute inflammatory response that result in attenuated performance for as long as 1 to 3 days. In competitive soccer though, multiple matches are performed within a small-time frame resulting in inadequate muscle recovery and reduced field performance. Supplementation with milk proteins following intense exercise protocols has been shown to stimulate protein synthesis and facilitate muscle recovery. Thus, the aim of the present investigation is to examine the effects of milk protein supplementation on muscle recovery and soccer-specific performance during an in-season microcycle with two matches performed three days apart.
Detailed Description
In a double-blind, cross over, repeated measures design 20 men soccer players will receive either placebo (PLA) or milk protein isolate (PRO, 80% casein-20% whey) throughout recovery following two matches performed three days apart. On match days, players will receive a dose immediately after the match (PLA vs PRO: 25g of protein) and then at 3h (PLA vs PRO: 30g of protein) and 6h (PLA vs PRO: 25g of protein) post-match. On each day of the remaining days, players will consume a single dose of PLA or PRO (20g of protein) with breakfast. All players will participate in regular in-season training following matches. Field activity during both matches and daily practices will be monitored using GPS devices. Heart rate will be continuously recorded during each match and training session. Blood samples will be collected at baseline as well as 2 hours after the first match, daily for three days after the first match, 2 hours after the second match and daily for 3 days after the second match. Performance (isokinetic strength, 20-m speed, repeated sprint ability) and muscle soreness will be assessed at baseline daily for 3 days after both matches. Muscle biopsies from vastus lateralis will be collected at baseline and one day after each match.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Skeletal Muscle Damage, Muscle Inflammation, Muscle Recovery, Soccer Performance
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Protein
Arm Type
Experimental
Arm Description
On the match day, 25g of protein consumed immediately after the match and then 30g at 3h (+3h) and 25g at 6h (+6h). On each day of the remaining days, 20 g of protein consumed with breakfast.
Arm Title
Placebo
Arm Type
Active Comparator
Arm Description
On the match day, 500 ml received received orally immediately post-match and then at +3h and +6h. On the remaining days, 500 ml daily with breakfast.
Intervention Type
Dietary Supplement
Intervention Name(s)
Milk protein isolate
Intervention Description
Milk protein isolate in a powder form consisted of 80% casein and 20% whey protein. 20g were diluted into 500 ml water
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
500 mL drink that contained water (375 mL), sugar-free cordial (125 mL) and 2 g of low-calorie glucose/dextrose powder.
Primary Outcome Measure Information:
Title
Change in creatine kinase in plasma
Description
Concentration of creatine kinase will be measured in plasma
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in uric acid in plasma
Description
Concentration of uric acid will be measured in plasma
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in protein carbonyls in blood
Description
Concentration of protein carbonyls will be measured in red blood cells
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in total antioxidant capacity
Description
Total antioxidant capacity will be measured in plasma
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in reduced glutathione in blood
Description
Concentration of reduced glutathione will be measured in in red blood cells
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in oxidized glutathione in blood
Description
Concentration of oxidized glutathione will be measured in red blood cells
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in malondialdehyde in blood
Description
Concentration of malondialdehyde will be measured in serum
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in catalase activity
Description
Catalase activity will be measured in red blood cells
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in protein carbonyls in muscle
Description
Concentration of protein carbonyls will be measured in muscle
Time Frame
At baseline, 24h post-Match 1 and 24h post-Match 2
Title
Change in intracellular signaling proteins in muscle
Description
Phosphorylation levels of Akt, mammalian target of rapamycin (mTOR) and p70S6K will be measure using western blotting.
Time Frame
At baseline, 24h post-Match 1 and 24h post-Match 2
Title
Change in proteasome activities in muscle
Description
Chymotrypsin-like (CT-L), caspase-like (C-L) and trypsin-like (T-L) proteasome activities will be assayed with hydrolysis of the fluorogenic peptide LLVY-AMC, LLE-AMC and LSTR-AMC, respectively.
Time Frame
At baseline, 24h post-Match 1 and 24h post-Match 2
Title
Change in satellite cells in muscle
Description
Pax7, Myf5, MyoD and Myogenin will be measured in order to quantify quiescent, activated, proliferated-differentiated and fused satellite cells respectively.
Time Frame
At baseline, 24h post-Match 1 and 24h post-Match 2
Title
Change in repeated Sprint Ability
Description
5 x 30 m sprints will be performed with 25 seconds rest in-between. Mean time for 5 sprints and fatigue index will be calculated.
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in countermovement jump
Description
Countermovement jump will be assessed on a contact platform
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in isokinetic strength of lower limbs
Description
Isokinetic strength will be assessed on an isokinetic dynamometer for both knee extensors and knee flexors at 120 and 180 degrees.
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Change in match activity
Description
Match activity will be continuously recorded during both matches using GPS technology.
Time Frame
During Match 1 and Match 2
Title
Change in heart rate
Description
Heart rate will be continuously recorded during both matches using the Team Polar system.
Time Frame
During Match 1 and Match 2
Secondary Outcome Measure Information:
Title
Change in delayed onset of muscle soreness
Description
Muscle soreness will assessed during palpation of the muscle belly and the distal region of relaxed vastus medialis, vastus lateralis and rectus femoris following three repetitions of of a full squat. Subjects will rate their DOMS on a visual analogue scale (0-10).
Time Frame
At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2
Title
Dietary intake
Description
Dietary intake will be assessed using 7-day diet recalls.
Time Frame
Over a 7-day period at baseline.
Title
Change in white blood cell count.
Description
White blood cell count will be measured using an automatic blood analyzer.
Time Frame
At baseline, immediately after Match 1, at 24h, 48h and 72h post-Match 1 as well as immediately after Match 2 and at 24h, 48h and 72h post-Match 2.
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
i) participation at elite level (top three division leagues) of soccer competition for at least five years, ii) abstain from consumption of performance-enhancing supplements, antioxidant supplements and medications (for at least 6 months before and during the study), iv) participate in at least six two-hour training sessions per week and played at least one match per week and v) non-smokers.
Exclusion Criteria:
i) a known milk intolerance or allergy, ii) a recent febrile illness, iii) history of muscle lesion, iv) lower limb trauma and v) metabolic diseases.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
ATHANASIOS POULIOS, PhDc
Organizational Affiliation
UNIVERSITY OF THESSALY, SCHOOL OF PHYSICAL EDUCATION & SPORTS SCIENCES
Official's Role
Principal Investigator
Facility Information:
Facility Name
Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly
City
Tríkala
ZIP/Postal Code
42100
Country
Greece
12. IPD Sharing Statement
Learn more about this trial
Protein Supplementation and Muscle Recovery in Football
We'll reach out to this number within 24 hrs